BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.490
-0.230 (-6.18%)
At close: May 22, 2026, 4:00 PM EDT
3.500
+0.010 (0.29%)
After-hours: May 22, 2026, 7:36 PM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $25.13 million as of May 22, 2026. Its market cap has increased by 107.73% in one year.
Market Cap
25.13M
Enterprise Value
-4.91M
1-Year Change
107.73%
Ranking
Category
Stock Price
$3.49
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has decreased from $26.00M to $25.13M, a decrease of -3.33%. That is a compound annual growth rate of -0.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 27.00M | 101.49% |
| Dec 31, 2025 | 13.40M | -46.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allarity Therapeutics | 27.37M |
| Tempest Therapeutics | 26.68M |
| Palatin Technologies | 25.70M |
| Vistagen Therapeutics | 25.63M |
| Cellectar Biosciences | 25.57M |
| Jasper Therapeutics | 25.28M |
| Celularity | 25.09M |
| Longeveron | 24.02M |